STATCenter·
STAT+: Makers of rare disease drugs seek exemption from Trump’s price-cut pilots
A coalition of biotech firms is lobbying to exclude orphan drugs from new federal pilot programs aimed at lowering Medicare drug costs.
Read at STAT →
Health · 1 sources covering this
STAT+: Makers of rare disease drugs seek exemption from Trump’s price-cut pilots
A coalition of biotech firms is lobbying to exclude orphan drugs from new federal pilot programs aimed at lowering Medicare drug costs.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/c6ad3afeb1601dff32eb6071b297d094490f5b6b" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Makers of rare disease drugs seek exemption from Trump’s price-cut pilots"></iframe>
